Flora Sofia
YOU?
Author Swipe
View article: #3498 LONG-COVID IN PATIENTS ON HEMODIALYSIS: A SINGLE CENTER ANALYSIS
#3498 LONG-COVID IN PATIENTS ON HEMODIALYSIS: A SINGLE CENTER ANALYSIS Open
Background and Aims It is known that maintenance hemodialysis (MHD) patients have a high risk of initial mortality from COVID-19. Concurrently, the Post-COVID-19 Syndrome also appears to be highly prevalent between them. However, in the ge…
View article: Prevalence of SARS-CoV-2 Cellular and Humoral Immunity Amongst Patients on Dialysis After the First Vaccination Campaign
Prevalence of SARS-CoV-2 Cellular and Humoral Immunity Amongst Patients on Dialysis After the First Vaccination Campaign Open
Background: Immunisation remains critical in prevention of serious COVID-19 infection. This study aimed to characterise the prevalence of humoral and cellular immunity in patients on maintenance dialysis in a nephrology centre 8 months aft…
View article: MO818: PTH Levels and Mortality in Incident Haemodialysis Patients
MO818: PTH Levels and Mortality in Incident Haemodialysis Patients Open
BACKGROUND AND AIMS Serum intact parathyroid hormone (iPTH) is associated with the prognosis of haemodialysis (HD) patients; however, its optimal range for reducing mortality remains unknown. The aim of this study was to assess the associa…
View article: MO911: Prevalence of SARS-COV-2 Cellular and Humoral Immunity in Dialysis Patients After 8 Months of Vaccination Campaign in Portugal
MO911: Prevalence of SARS-COV-2 Cellular and Humoral Immunity in Dialysis Patients After 8 Months of Vaccination Campaign in Portugal Open
BACKGROUND AND AIMS Immunization of dialysis dependent patients remains the single most important protective approach in prevention of serious COVID-19 infection. This study aims to characterize the prevalence of humoral and cellular immun…
View article: Vascular access type and mortality in elderly incident hemodialysis patients
Vascular access type and mortality in elderly incident hemodialysis patients Open
Introduction: The ideal vascular access type for elderly hemodialysis (HD) patients remains debatable. The aim of this study was to analyze the association between patterns of vascular access use within the first year of HD and mortality i…
View article: Humoral response to <scp>BNT162b2 mRNA COVID</scp> ‐19 vaccine in peritoneal and hemodialysis patients: A comparative study
Humoral response to <span>BNT162b2 mRNA COVID</span> ‐19 vaccine in peritoneal and hemodialysis patients: A comparative study Open
Introduction Maintenance dialysis patients (MDP) are at higher risk of exposure with increased mortality from COVID‐19 with generalized immunization becoming the cornerstone in prevention. This study aims to compare humoral response betwee…
View article: Risk Factors for Low Humoral Response to BNT-162b2 In Hemodialysis Patients
Risk Factors for Low Humoral Response to BNT-162b2 In Hemodialysis Patients Open
Introduction Maintenance Hemodialysis (HD) patients are at higher risk of both infection and mortality associated with the new coronavirus 2. Immunization through large-scale vaccination is the cornerstone of infection prevention in this p…
View article: Humoral Response to BNT162b2 mRNA Covid19 Vaccine in Peritoneal and Hemodialysis Patients: a Comparative Study
Humoral Response to BNT162b2 mRNA Covid19 Vaccine in Peritoneal and Hemodialysis Patients: a Comparative Study Open
Introduction Generalized immunization against COVID19 has become the cornerstone in prevention of severe acute respiratory syndrome associated with this pandemic. Maintenance dialysis patients (MDP) are at higher risk of both exposure and …
View article: POS-610 PREDICTORS OF ERYTHROPOIETIN HIPORESPONSIVENESS IN PREVALENT PATIENTS ON HEMODIALYSIS: A CROSS-SECTIONAL STUDY
POS-610 PREDICTORS OF ERYTHROPOIETIN HIPORESPONSIVENESS IN PREVALENT PATIENTS ON HEMODIALYSIS: A CROSS-SECTIONAL STUDY Open
Anemia resistant to erythropoietin stimulating agents (ESAs) is a risk factor for mortality in hemodialysis (HD). Determining the causes of hyporesponsiveness may help overcome the resistance. The aim of this study was to investigate the r…
View article: POS-611 FERRITIN: ONE BIOMARKER, MULTIPLE INTERPRETATIONS
POS-611 FERRITIN: ONE BIOMARKER, MULTIPLE INTERPRETATIONS Open
Use of erythropoiesis-stimulating agents (ESAs) has improved the management of anemia in patients on hemodialysis (HD). Iron deficiency and inflammation are causes of ESAs resistance and are both common among HD patients. Ferritin has been…
View article: P1529MORTALITY PREDICTORS IN INCIDENT HEMODIALYSIS PATIENTS - HAVE HEY CHANGED IN TEN YEARS?
P1529MORTALITY PREDICTORS IN INCIDENT HEMODIALYSIS PATIENTS - HAVE HEY CHANGED IN TEN YEARS? Open
Background and Aims In the last years there has been an increase in elderly patients with multiple comorbidities inducing hemodialysis (HD). Since dialysis treatment itself may be associated with a further deterioration in functional statu…
View article: P1410IMPACT OF VITAMIN D SUPPLEMENTATION ON CKD-MBD HEMODIALYSIS PATIENTS - A PROSPECTIVE STUDY
P1410IMPACT OF VITAMIN D SUPPLEMENTATION ON CKD-MBD HEMODIALYSIS PATIENTS - A PROSPECTIVE STUDY Open
Background and Aims There are evidences suggesting that 50-90% of hemodialysis (HD) patients are vitamin D deficient [25(OH) D level <20 ng/mL] or insufficient (between 21 to 29 ng/mL). Recent guidelines recommend evaluation and supplem…
View article: P0012SHOULD WE DEFINE A NEW STANDARD PRESCRIPTION OF BICARBONATE (HCO3-) IN HEMODIALYSIS (HD)?
P0012SHOULD WE DEFINE A NEW STANDARD PRESCRIPTION OF BICARBONATE (HCO3-) IN HEMODIALYSIS (HD)? Open
Background and Aims One of the aims of the regular, intermittent HD therapy prescribed for patients with end-stage chronic kidney disease, is correction of metabolic acidosis by addition of HCO3- to dialysate fluid. The KDOQI guidelines th…
View article: SP315ARCHITECT HEPATITIS C VIRUS (HCV) CORE ANTIGEN TEST: A HCV RNA SCREENING ALTERNATIVE IN END-STAGE RENAL DISEASE (ESRD) AND HEMODIALYSIS PATIENTS?
SP315ARCHITECT HEPATITIS C VIRUS (HCV) CORE ANTIGEN TEST: A HCV RNA SCREENING ALTERNATIVE IN END-STAGE RENAL DISEASE (ESRD) AND HEMODIALYSIS PATIENTS? Open
As a result little is known , when looked for, on comparative data between the two on cardio-renal diseases and associated risk factors.The aim was to investigate the sociodemography, anthropometrics, hemodynamic and metabolic variables fo…